The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Randomized Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Colon Carcinoma Dukes C
Official Title: A Prospectively Randomized Phase III Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Patients With Operated Colon Carcinoma Dukes C (Stage III; T1-4, N1-30, M0).
Study ID: NCT00309530
Brief Summary: This clinical investigation examined the effectivity 5-fluorouracil, of adding levamisol or interferon to 5-fluorouracil, and of a 5-fluorouracil/levamisol/interferon triple combination, in terms of recurrence-free and overall survival in curatively operable colon carcinoma Stage III.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Hospital Guessing, Guessing, Burgenland, Austria
Hospital Oberpullendorf, Oberpullendorf, Burgenland, Austria
Hospital BHB St. Veit/Glan, Surgery, St. Veit a. d. Glan, Carinthia, Austria
State Hospital Wolfsberg, Wolfsberg, Carinthia, Austria
Medical University of Graz, Oncology, Graz, Styria, Austria
State Hospital Leoben, Surgery, Leoben, Styria, Austria
Hospital St. Vinzenz, Zams, Tyrol, Austria
State Hospital Kirchdorf, Kirchdorf, Upper Austria, Austria
General Hospital Linz, Linz, Upper Austria, Austria
Hospital BHB Linz, Linz, Upper Austria, Austria
State Hospital Voecklabruck, Internal Medicine, Voecklabruck, Upper Austria, Austria
Hospital Kreuzschwestern Wels, Wels, Upper Austria, Austria
State Hospital Feldkirch, Feldkirch, Vorarlberg, Austria
Paracelsus Medical University Salzburg - Oncology, Salzburg, , Austria
Medical University Vienna, General Hospital, Vienna, , Austria
Wilheminenspital, Internal Medicin I, Vienna, , Austria
Name: Raimund Jakesz, MD
Affiliation: Austrian Breast & Colorectal Cancer Study Group
Role: PRINCIPAL_INVESTIGATOR